Dr. Eric K. Singhi shares his insights into the advantages of the subcutaneous formulation of Opdivo versus the IV version for patients with solid tumors.
A method known as intradermal vaccination allows a single ... Food and Drug Administration for a single 0.5 milliliter subcutaneous injection, followed by a second 0.5 milliliter dose four weeks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback